Health Trials

Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer

ConditionsOvarian CancerOvarian NeoplasmsOvarian Carcinoma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorDana-Farber Cancer Institute

About this trial

This research is being done to test a new communication tool for people with ovarian cancer, caregivers, and clinicians.

The name of the intervention in this research study is:

-Collaborative Agenda-Setting Intervention (CASI)

Eligibility criteria

Qualifiers

At least 18 years old

Able to speak, understand, and respond to questions written in English

Willing to be audio recorded

Have a diagnosis of advanced ovarian cancer (defined as stage III, stage IV, or recurrent disease)

Disqualifiers

Age of <18 years

Unable to consent

Trial design

Treatments tested in this trial

  • Collaborative Agenda-Setting Intervention

Treatment groups

112 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Dana-Farber Cancer Institute

Lead sponsor

National Institute of Nursing Research (NINR)

Collaborator

Source ClinicalTrials.gov